New DBS device for Parkinson’s approved for US patients


Author: AdminPublished: 24 June 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The US Food and Drug Administration (FDA) has approved a new implantable deep brain stimulation device (DBS) called the Brio Neurostimulation System.

Previously the Activa DBS Therapy System manufactured by Medtronic was the only device available to patients in the US.

Like the Activa system, the newly approved Brio system consists of a battery-powered rechargeable electrical pulse generator that is inserted under the skin of the upper chest and wires that lead to electrodes implanted in the brain.

The new Brio system is made by St. Jude Medical.

Go Back

Share this story


Related articles

newspaper illustration

Global update

Parkinson’s in the news: June

A roundup of Parkinson’s news stories in June

Monkey with Parkinson's


Scientists genetically engineer world’s first monkey with Parkinson’s disease

Controversial research in Japan could lead to breakthroughs

Moving Day with confetti

Global update

Exclusive interview: John Lehr and James Beck of the Parkinson’s Foundation

Meet the Parkinson’s Foundation CEO and Chief Scientific Officer